We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Wegovy improved functional class vs. placebo at 1 year ...
Higher baseline serum magnesium levels are linked to a higher risk for cardiac events in HFmrEF/HFpEF, while empagliflozin treatment shows a lower risk for these events in those with higher magnesium.
Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...
Adding ertugliflozin (Steglatro; Merck Sharp & Dohme), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, to other therapies significantly reduces functional mitral regurgitation (MR) secondary to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback